CBE ID
0578
1.5 Project
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description
This measure identifies the percentage of patients who had a TSH baseline measurement at the start of amiodarone therapy
Measure Specs
General Information
1.7 Measure Type
1.3 Electronic Clinical Quality Measure (eCQM)
No
1.8 Level of Analysis
1.9 Care Setting
1.20 Types of Data Sources
Numerator
1.14 Numerator
Patients in the denominator who had TSH baseline measurement within 60 days prior to or 30 days after the amiodarone start date
Denominator
1.15 Denominator
Adult patients who started amiodarone (see the drug list below) at any time during the first 11 months of the measurement year
Exclusions
Exclusions
No claims with procedure codes for ´Thyroidectomy, total´ (see list of procedure codes below) No claims for services in hospital from amiodarone start date - 60 days to amiodarone start date - 30 days)
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Cardiovascular Project 2013-2014
Initial Endorsement
Last Updated
Removal Date
Point of Contact
Steward Organization
Resolution Health, Inc.
Steward POC email
Importance
Care Gaps
Feasibility
Scientific Acceptability
Risk Adjustment
Risk Adjustment
Use & Usability
Use
6.1.2 Current or Planned Use(s)
Public Comments